Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Astec Industries | ASTE | 5. nov 2024 | 33.28 | +2.81 |
Astera Labs | ALAB | 5. nov 2024 | 95.91 | +37.70 |
Astrana Health | ASTH | 5. nov 2024 | 56.00 | +3.13 |
AstraZeneca ADR | AZN | 5. nov 2024 | 66.27 | -7.22 |
Astria Therapeutics | ATXS | 5. nov 2024 | 11.51 | -0.26 |
Astronics | ATRO | 5. nov 2024 | 18.58 | +2.14 |
AstroNova | ALOT | 5. nov 2024 | 12.55 | +3.04 |
Astrotech | ASTC | 5. nov 2024 | 7.00 | +1.60 |
Asure Software | ASUR | 5. nov 2024 | 8.78 | +5.72 |
AT&T | T | 5. nov 2024 | 22.05 | +0.59 |
AT&T A Pref | T-A | 5. nov 2024 | 22.38 | +1.84 |
AT&T C Pref | T-C | 5. nov 2024 | 21.11 | +1.15 |
ATA Creativity Global ADR | AACG | 5. nov 2024 | 1.03 | -0.96 |
Atai Life Sciences BV | ATAI | 5. nov 2024 | 1.08 | 0.00 |
Atara Biotherapeutics | ATRA | 5. nov 2024 | 10.28 | -11.61 |
Atea Pharmaceuticals | AVIR | 5. nov 2024 | 3.36 | +0.30 |
Aterian | ATER | 5. nov 2024 | 2.94 | +0.34 |
Athena Technology Acquisition II | ATEK | 5. nov 2024 | 11.71 | -9.22 |
Athene A Pref | ATH-A | 5. nov 2024 | 25.60 | +0.59 |
Athene B Pref | ATH-B | 5. nov 2024 | 23.15 | +1.80 |
Athene C Pref | ATH-C | 5. nov 2024 | 25.29 | +0.20 |
Athene D Pref | ATH-D | 5. nov 2024 | 20.13 | +2.44 |
Athene Holding | ATH-E | 5. nov 2024 | 27.01 | +0.56 |
Athira Pharma | ATHA | 5. nov 2024 | 0.75 | +17.21 |
Ati Physical Therapy A | ATIP | 5. nov 2024 | 3.09 | -40.09 |
ATIF Holdings | ATIF | 5. nov 2024 | 0.93 | +14.81 |
Atkore | ATKR | 5. nov 2024 | 90.84 | +2.77 |
Atlanta Braves A | BATRA | 5. nov 2024 | 43.15 | +0.44 |
Atlanta Braves C | BATRK | 5. nov 2024 | 40.76 | +0.30 |
Atlantic American | AAME | 5. nov 2024 | 1.62 | -3.57 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.